Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers

被引：0
|
作者：
Henk van der Poel
Laurence Klotz
Gerald Andriole
Abdel-Rahmène Azzouzi
Anders Bjartell
Olivier Cussenot
Freddy Hamdy
Markus Graefen
Paolo Palma
Arturo Rodriguez Rivera
Christian G. Stief
机构：
[1] Netherlands Cancer Institute,Department of Urology
[2] University of Toronto,Division of Urology, Sunnybrook Health Science Centre
[3] Washington University St Louis,Division of Urology, Department of Surgery
[4] CHU d’Angers,Service d’Urologie
[5] Sahlgrenska Academy at the University of Gothenburg,Department of Urology, Institute of Clinical Sciences
[6] UPMC Univ Paris 06,Institute Universitaire de Cancerologie
[7] GRC-05,Nuffield Department of Surgical Sciences
[8] ONCOTYPE-Uro,Martini
[9] University of Oxford,Clinic Prostate Cancer Center
[10] University Medical Center Hamburg-Eppendorf,Department of Urology
[11] Universidade Estadual de Campinas,Department of Urology, Klinikum Großhadern, University Hospital Munich
[12] Hospital General Tlahuac,Großhadern
[13] Ludwig-Maximillians-University München,undefined
来源：
World Journal of Urology | 2015年 / 33卷
关键词：
Prostate cancer; Focal therapy; Active surveillance; Low risk; Intermediate risk; Consensus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：907 / 916
页数：9
相关论文
共 50 条
  • [1] Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers
    van der Poel, Henk
    Klotz, Laurence
    Andriole, Gerald
    Azzouzi, Abdel-Rahmene
    Bjartell, Anders
    Cussenot, Olivier
    Hamdy, Freddy
    Graefen, Markus
    Palma, Paolo
    Rodriguez Rivera, Arturo
    Stief, Christian G.
    WORLD JOURNAL OF UROLOGY, 2015, 33 (07) : 907 - 916
  • [2] Active surveillance in low- and intermediate-risk prostate cancer
    Cerbone, Linda
    Regine, Giovanni
    Calabro, Fabio
    ASIAN JOURNAL OF ANDROLOGY, 2024, 26 (06): : 582 - 583
  • [3] Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance
    Courtney, P. Travis
    Deka, Rishi
    Kotha, Nikhil, V
    Cherry, Daniel R.
    Salans, Mia A.
    Nelson, Tyler J.
    Kumar, Abhishek
    Luterstein, Elaine
    Yip, Anthony T.
    Nalawade, Vinit
    Parsons, J. Kellogg
    Kader, A. Karim
    Stewart, Tyler F.
    Rose, Brent S.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (02): : 151 - +
  • [4] Patterns of multispecialty care for low- and intermediate-risk prostate cancer in the use of active surveillance
    Zambrano, Ibardo A.
    Hwang, Soohyun
    Basak, Ram
    Spratte, Brooke Namboodri
    Filson, Christopher P.
    Jacobs, Bruce L.
    Tan, Hung-Jui
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (09) : 388.e1 - 388.e8
  • [5] FOCAL CRYOTHERAPY FOR LOW- TO INTERMEDIATE-RISK PROSTATE CANCER: LONG TERM RESULTS AND MATCHED PAIR COMPARISON WITH ACTIVE SURVEILLANCE
    Marra, Giancarlo
    Soeterik, Timo
    Oreggia, Davide
    Pasquali, Caio
    Tourinho-Barbosa, Rafael
    Moschini, Marco
    Filippini, Claudia
    van Melick, Harm H. E.
    van den Bergh, Roderick C. N.
    Gontero, Paolo
    Cathala, Nathalie
    Macek, Petr
    Sanchez-Salas, Rafael
    Cathelineau, Xavier
    JOURNAL OF UROLOGY, 2021, 206 : E817 - E817
  • [6] Oncologic outcomes of radiation therapy following active surveillance for low- and intermediate-risk localized prostate cancer.
    Ahmad, Ardalan
    Chua, Melvin
    Murgic, Jure
    Raziee, Hamid Reza
    Hosni, Ali
    De Moraes, Fabio Ynoe
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [7] Active surveillance and focal therapy for low-intermediate risk prostate cancer
    Klotz, Laurence
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2015, 4 (03) : 342 - 354
  • [8] Current focal therapies for the treatment of low- and intermediate-risk prostate cancer
    Malorgio, Antonio
    ASIAN JOURNAL OF ANDROLOGY, 2024, 26 (06): : 592 - 594
  • [9] A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer
    Kato, Takuma
    Tohi, Yoichiro
    Honda, Tomoko
    Matsuda, Iori
    Osaki, Yu
    Naito, Hirohito
    Matsuoka, Yuki
    Okazoe, Homare
    Taoka, Rikiya
    Tsunemori, Hiroyuki
    Ueda, Nobufumi
    Sugimoto, Mikio
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (03) : 289 - 297
  • [10] No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance
    Cyll, Karolina
    Loffeler, Sven
    Carlsen, Birgitte
    Skogstad, Karin
    Plathan, May Lisbeth
    Landquist, Martin
    Haug, Erik Skaaheim
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345